Maureen Shuh, MD
Dr. Shuh received her undergraduate degree in Microbiology & Immunology from the University of California at Berkeley. For her Ph.D. in Biology (subprogram in Molecular Biology, Cell Biology, and Biochemistry/MCB) at Brown University, she studied the molecular mechanisms V(D)J recombination in B lymphocytes. She completed her postdoctoral fellowship at the National Cancer Institute (National Institutes of Health), studying the transcriptional regulation of human T cell lymphotrophic virus type I (HTLV-1) in cancer induction of T lymphocytes. Between her undergraduate and graduate education, she joined Chiron Corporation (now Novartis Institutes for BioMedical Research in Emeryville, CA) where she was involved in the AIDS vaccine project. She continued her HTLV-1 research as an Assistant, then Associate, professor in the Department of Biological Sciences at Loyola University New Orleans and then moved to the College of Pharmacy at Xavier University of Louisiana as an Associate Professor. More recently, she worked with the Office of Research at Tulane University, assisting in implementing the research goals in Tulane’s strategic plan.